
Department of Cardiothoracic & Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, USACardiac surgery; Cardiac regenerative therapy; Tissue engineering; Heart-lung transplantation; Mechanical circulatory support; Regenerative medicine; induced pluripotent stem cell

Regenerative therapy has recently emerged for treating various diseases, and numerous preclinical and clinical studies using various types of stem cells and tissue engineering have been proven to improve organ functions. For example, induced pluripotent stem cells (iPSC) represent an unlimited source of a variety of cells because of their great potential for differentiation and are therefore one of the most promising sources of cells for regenerative therapy. This Special Issue is calling for both original articles and reviews providing the readers of Global Translational Medicine with a comprehensive elucidation about regenerative therapy, stem cell therapy, and induced pluripotent stem cells.
Author registration and submission: https://accscience.com/user/login. Submit your paper along with a cover letter, including the special issue title. Your paper will undergo a fair peer review and be published immediately after acceptance and will be available to an international audience.
Cardiac regenerative therapy using induced pluripotent stem cells
Advancements in cardiac regenerative therapy: Scalable human iPSC-derived cardiomyocyte differentiation and maturation

